Internal Medicine
Online ISSN : 1349-7235
Print ISSN : 0918-2918
ISSN-L : 0918-2918
CASE REPORTS
An Iron-chelating Agent Improved the Cardiac Function in a Patient with Severe Heart Failure Due to Hereditary Hemochromatosis
Akito Setoguchi, Hiroaki Kawano, Shinji Okano, Tomohiro Honda, Takeharu Kato, Sumito Dateki, Akira Senoo, Yomi Nakashima, Tetsufumi Motokawa, Yuki Ueno, Ryohei Akashi, Tsuyoshi Yonekura, Eijun Sueyoshi, Satoshi Ikeda, Yasushi Miyazaki, Koji Maemura
著者情報
キーワード: iron overload, cardiomyopathy, tricuspid regurgitation
ジャーナル オープンアクセス

2024 年 63 巻 2 号 p. 253-258

Browse “Advance online publication” version
詳細
PDFをダウンロード (1787K)
メタデータをダウンロード RIS形式

(EndNote、Reference Manager、ProCite、RefWorksとの互換性あり)

BIB TEX形式

(BibDesk、LaTeXとの互換性あり)

テキスト
メタデータのダウンロード方法
発行機関連絡先
抄録

A 24-year-old man was admitted to our hospital because of severe heart failure. Although he was treated with diuretics and positive inotropic agents, his heart failure progressed. An endomyocardial biopsy revealed iron deposition in his myocytes. Finally, he was diagnosed with hereditary hemochromatosis. After starting administration of an iron-chelating agent in addition to conventional treatment for heart failure, his condition improved. We should consider hemochromatosis in heart failure patients with severe right ventricular dysfunction in addition to left ventricular dysfunction.

著者関連情報
© 2024 by The Japanese Society of Internal Medicine

This article is licensed under a Creative Commons [Attribution-NonCommercial-NoDerivatives 4.0 International] license.
https://creativecommons.org/licenses/by-nc-nd/4.0/
前の記事 次の記事
お気に入り & アラート

閲覧履歴
前身誌

Japanese Journal of Medicine

このページを共有する
feedback
 Top